Evotec and Variant Bio enter strategic partnership to discover and develop fibrosis treatments
EQS Group
EQS-News: Evotec SE / Key word(s): Miscellaneous
Evotec and Variant Bio enter strategic partnership to discover and develop..
EQS-News: Evotec SE / Key word(s): Miscellaneous
Evotec and Variant Bio enter strategic partnership to discover and develop..
– ATH434 Improved Motor Performance and General Function in a Primate Model of Parkinson’s Disease –– ATH434-201 Phase 2..
LEXINGTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated..